Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia

Eur J Intern Med. 2022 May:99:106-108. doi: 10.1016/j.ejim.2022.01.031. Epub 2022 Jan 21.

Abstract

Image, graphical abstract

Keywords: COVID-19; Low molecular weight heparin; Outcomes; Prophylactic; Therapeutic.

Publication types

  • Letter

MeSH terms

  • Anticoagulants / therapeutic use
  • COVID-19*
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • bemiparin